1. Home
  2. SABS vs HWH Comparison

SABS vs HWH Comparison

Compare SABS & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SABS
  • HWH
  • Stock Information
  • Founded
  • SABS 2014
  • HWH 2021
  • Country
  • SABS United States
  • HWH United States
  • Employees
  • SABS N/A
  • HWH N/A
  • Industry
  • SABS Biotechnology: Pharmaceutical Preparations
  • HWH Other Pharmaceuticals
  • Sector
  • SABS Health Care
  • HWH Health Care
  • Exchange
  • SABS Nasdaq
  • HWH Nasdaq
  • Market Cap
  • SABS 15.8M
  • HWH 8.5M
  • IPO Year
  • SABS N/A
  • HWH N/A
  • Fundamental
  • Price
  • SABS $2.64
  • HWH $1.30
  • Analyst Decision
  • SABS Strong Buy
  • HWH
  • Analyst Count
  • SABS 5
  • HWH 0
  • Target Price
  • SABS $11.80
  • HWH N/A
  • AVG Volume (30 Days)
  • SABS 35.4K
  • HWH 45.6K
  • Earning Date
  • SABS 08-07-2025
  • HWH 08-11-2025
  • Dividend Yield
  • SABS N/A
  • HWH N/A
  • EPS Growth
  • SABS N/A
  • HWH N/A
  • EPS
  • SABS N/A
  • HWH N/A
  • Revenue
  • SABS $377,835.00
  • HWH $1,262,664.00
  • Revenue This Year
  • SABS N/A
  • HWH N/A
  • Revenue Next Year
  • SABS N/A
  • HWH N/A
  • P/E Ratio
  • SABS N/A
  • HWH N/A
  • Revenue Growth
  • SABS N/A
  • HWH 37.84
  • 52 Week Low
  • SABS $1.00
  • HWH $0.90
  • 52 Week High
  • SABS $5.01
  • HWH $7.20
  • Technical
  • Relative Strength Index (RSI)
  • SABS 77.22
  • HWH 47.36
  • Support Level
  • SABS $1.72
  • HWH $1.35
  • Resistance Level
  • SABS $2.72
  • HWH $1.47
  • Average True Range (ATR)
  • SABS 0.19
  • HWH 0.10
  • MACD
  • SABS 0.10
  • HWH 0.00
  • Stochastic Oscillator
  • SABS 91.89
  • HWH 42.69

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

About HWH HWH International Inc.

HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.

Share on Social Networks: